Report overview
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics Drugs. This report contains market size and forecasts of Peptide Therapeutics Drugs in global, including the following market information:
Global Peptide Therapeutics Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Peptide Therapeutics Drugs market was valued at US$ 35550 million in 2022 and is projected to reach US$ 63390 million by 2029, at a CAGR of 8.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
We surveyed the Peptide Therapeutics Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Therapeutics Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Peptide Therapeutics Drugs Market Segment Percentages, by Type, 2022 (%)
Injection
Oral
Other
Global Peptide Therapeutics Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Peptide Therapeutics Drugs Market Segment Percentages, by Application, 2022 (%)
Cancer
Metabolic Disorders
Central Nervous System
Other
Global Peptide Therapeutics Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Peptide Therapeutics Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Therapeutics Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Peptide Therapeutics Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Eli Lilly
Novo Nordisk
Takeda
Teva
Novartis
AstraZeneca
Ipsen
AbbVie
Allergan
Ferring
Merck
JNJ
Tarix Pharmaceuticals
Lonza
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide Therapeutics Drugs, market overview.
Chapter 2: Global Peptide Therapeutics Drugs market size in revenue.
Chapter 3: Detailed analysis of Peptide Therapeutics Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
